scholarly journals 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Thyroid ◽  
2016 ◽  
Vol 26 (10) ◽  
pp. 1343-1421 ◽  
Author(s):  
Douglas S. Ross ◽  
Henry B. Burch ◽  
David S. Cooper ◽  
M. Carol Greenlee ◽  
Peter Laurberg ◽  
...  
Keyword(s):  
American Thyroid Association ◽  
Diagnosis And Management

scholarly journals Advancements in Clinical Thyroidology in 2016

2016 ◽  
Vol 12 (02) ◽  
pp. 83
Author(s):  
Maria Brito ◽  
Keyword(s):  
Thyroid Cancer ◽  
Differentiated Thyroid Cancer ◽  
Thyroid Nodules ◽  
Adult Patients ◽  
Graves Disease ◽  
American Thyroid Association ◽  
Diagnosis And Management ◽  
In Pregnancy

In this article, we summarize the seminal highlights of clinical thyroidology literature published in 2016. The main focus of these articles were thyroid nodules, thyroid cancer, cubclinical hypothyroidism in pregnancy, Graves℉ disease in pregnancy, the American Thyroid Association guidelines for adult patients with thyroid nodules and differentiated thyroid cancer, and the American Thyroid Association guidelines for the diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.

scholarly journals Review of American Thyroid Association guidelines for the diagnosis and management of thyroid disease during pregnancy and the postpartum

2018 ◽  
Vol 14 (3) ◽  
pp. 128-139
Author(s):  
Valentin V. Fadeyev
Keyword(s):  
Thyroid Disease ◽  
Critical Appraisal ◽  
Clinical Decision Making ◽  
Task Force ◽  
Synthesis Methods ◽  
American Thyroid Association ◽  
Thyroid Function Tests ◽  
Diagnosis And Management ◽  
Published Evidence ◽  
In Pregnancy

Thyroid disease in pregnancy is a common clinical problem. Since the guidelines for the management of these disorders by the American Thyroid Association (ATA) were first published in 2011, significant clinical and scientific advances have occurred in the field. The aim of these guidelines is to inform clinicians, patients, researchers, and health policy makers on published evidence relating to the diagnosis and management of thyroid disease in women during pregnancy, preconception, and the postpartum period. The specific clinical questions addressed in these guidelines were based on prior versions of the guidelines, stakeholder input, and input of task force members. Task force panel members were educated on knowledge synthesis methods, including electronic database searching, review and selection of relevant citations, and critical appraisal of selected studies. Published English language articles were eligible for inclusion. The American College of Physicians Guideline Grading System was used for critical appraisal of evidence and grading strength of recommendations. The guideline task force had complete editorial independence from the ATA. Competing interests of guideline task force members were regularly updated, managed, and communicated to the ATA and task force members. The revised guidelines for the management of thyroid disease in pregnancy include recommendations regarding the interpretation of thyroid function tests in pregnancy, iodine nutrition, thyroid autoantibodies and pregnancy complications, thyroid considerations in infertile women, hypothyroidism in pregnancy, thyrotoxicosis in pregnancy, thyroid nodules and cancer in pregnant women, fetal and neonatal considerations, thyroid disease and lactation, screening for thyroid dysfunction in pregnancy, and directions for future research. We have developed evidence-based recommendations to inform clinical decision-making in the management of thyroid disease in pregnant and postpartum women. While all care must be individualized, such recommendations provide, in our opinion, optimal care paradigms for patients with these disorders.

A Presidential Reflection

2014 ◽  
Vol 10 (02) ◽  
pp. 111
Author(s):  
Hossein Gharib ◽  
Keyword(s):  
Thyroid Disorders ◽  
American Thyroid Association ◽  
Medical Organization ◽  
Diagnosis And Management

I was honored to be elected in 2013 to serve as the President of the American Thyroid Association (ATA), a professional medical organization dedicated to the diagnosis and management of thyroid disorders. This brief report describes my 40-year involvement with the ATA, my experience as the president, and our accomplishments and challenges.

scholarly journals Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.

2017 ◽  
Vol 13 (3) ◽  
pp. 45-56 ◽  
Author(s):  
Valentin V. Fadeyev
Keyword(s):  
American Thyroid Association ◽  
Diagnosis And Management ◽  
Assessment Development ◽  
Evaluation Group

Тиреотоксикоз представляет собой клинический синдром и встречается при разных заболеваниях, которые подразумевают разные лечебные подходы. В представленных клинических рекомендациях обсуждаются доказательные подходы к диагностике и лечению заболеваний, протекающих с тиреотоксикозом, разработанные Американской Тиреоидной Ассоциацией (АТА); при этом речь идет об обновленном документе, первая версия которого была опубликована в 2011 году. За прошедшие пять лет было опубликовано достаточно много исследований, что потребовало обновления рекомендаций. Все представленные положения ранжированы по силе и уровню доказательности, в соответствие с системой GRAD (Grading of Recommendations, Assessment, Development, and Evaluation Group). Основными проблемами, которые обсуждаются в рекомендациях, являются: обследование пациентов с тиреотоксикозом, лечение болезни Грейвса (БГ) при помощи тиреостатических препаратов, радиоактивного йода и хирургии; лечение многоузлового токсического зоба и токсической аденомы; лечение БГ у детей и подростков; субклинический тиреотоксикоз, эндокринная орбитопатия, а также диагностика и лечение других заболеваний, протекающих с тиреотоксикозом. По сравнению с 2011 годом изменились подходы к обследованию пациентов с тиреотоксикозом с целью установления его этиологии, лечение тиреотоксикоза при БГ тиреостатическими препаратами, лечение тиреотоксикоза во время беременности и к подготовке пациентов к оперативному лечению. Расширен раздел рекомендаций, посвященных более редким причинам тиреотоксикоза. В итоге для клинической практики было предложено 124 рекомендации.

scholarly journals Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum

Thyroid ◽  
2011 ◽  
Vol 21 (10) ◽  
pp. 1081-1125 ◽  
Author(s):  
Alex Stagnaro-Green ◽  
Marcos Abalovich ◽  
Erik Alexander ◽  
Fereidoun Azizi ◽  
Jorge Mestman ◽  
...  
Keyword(s):  
Thyroid Disease ◽  
American Thyroid Association ◽  
Diagnosis And Management ◽  
Pregnancy And Postpartum

Linking medical needs and performance goals: clinical and laboratory perspectives on thyroid disease

1993 ◽  
Vol 39 (7) ◽  
pp. 1519-1524 ◽  
Author(s):  
I D Hay ◽  
G G Klee
Keyword(s):  
Thyroid Disease ◽  
Suppressive Therapy ◽  
Fourth Generation ◽  
American Thyroid Association ◽  
Case Examples ◽  
Diagnosis And Management ◽  
Medical Needs ◽  
Line Test ◽  
And Performance ◽  
Performance Guidelines

Abstract Diagnosis and management of thyroid disease benefit substantially from close interactions between clinicians and laboratorians. Clinicians desire reliable tests for diagnosis and management of both hypothyroidism and thyrotoxicosis. Traditionally, multitiered testing has been used, beginning with an index of free thyroxine concentration, which, if abnormal, has been followed by basal thyrotropin (TSH) measurements (for hypothyroidism) or thyrotropin-releasing hormone-stimulated TSH measurements (for thyrotoxicosis). Improvements in analytical methods for TSH have made it practical to use basal TSH measurements in serum as the first-line test for thyroid disease. However, performance guidelines are needed, because not all TSH assays work well in this role. The performance guidelines developed by the American Thyroid Association are reviewed to illustrate how they help to assure consistent analytical testing. Further improvements in TSH assays (third- and fourth-generation assays), which support measurements down to 0.01 mlU/L and 0.001 mIU/L, may provide additional advantages for classifying thyrotoxic patients and monitoring thyroxine-suppressive therapy in patients with thyroid cancer. The potential advantages of these newer assays are illustrated with case examples. Additional analytical performance monitors are proposed to help ensure that these next-generation TSH assays meet the expanded clinical needs.

scholarly journals The Treatment of Hypothyroidism in Pregnancy

2017 ◽  
Vol 24 (2) ◽  
pp. 155-160
Author(s):  
Rucsandra Dănciulescu Miulescu ◽  
Andrada Doina Mihai
Keyword(s):  
Pregnant Women ◽  
Subclinical Hypothyroidism ◽  
Thyroid Disease ◽  
Hormone Deficiency ◽  
Specific Reference ◽  
Overt Hypothyroidism ◽  
American Thyroid Association ◽  
Diagnosis And Management ◽  
Pregnancy And Postpartum ◽  
In Pregnancy

Abstract Hypothyroidism is a pathologic condition generated by the thyroid hormone deficiency. The American Thyroid Association advises for the screening of hypothyroidism beginning at 35 years and thereafter every 5 years in people at high risk for this condition: females older than 60 years, pregnant women, patients with other autoimmune disease or patients with a history of neck irradiation. In pregnant women, hypothyroidism can been associated with adverse effect for both mother and child. The „Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum“ recommends the treatment of maternal overt hypothyroidism: females with a thyrotropin (TSH) level higher than the trimester-specific reference interval and decreased free thyroxine (FT4), and females for which TSH level is higher than 10.0 mIU/L, irrespective of the FT4 value, with administration of oral levothyroxine. The goal of treatment of maternal overt hypothyroidism is to bring back the serum TSH values to the reference range specific for the pregnancy trimester. The Guidelines of the „European Thyroid Association for the Management of Subclinical Hypothyroidism in Pregnancy and in Children“ recommends treatment of pregnancy associated subclinical hypothyroidism with the following levothyroxine doses: „1.20 μg/kg/day for TSH≤4.2 mU/l, 1.42 μg/kg/day for TSH >4.2-10 and 2.33 μg/kg/day for overt hypothyroidism“. The „Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum“ and the „European Thyroid Association for the Management of Subclinical Hypothyroidism in Pregnancy and in Children“ do not recommend the treatment of isolated hypothyroxinemia in pregnancy.

Sign in / Sign up

Export Citation Format

Share Document